Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
REVIVA PHARMACEUTICALS HOLDINGS, INC. shareholders approved Ratification of the appointment of Moss Adams LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2023 at the 2023-11-13 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-11-13
Exact text from the filing
2. The proposal to ratify the appointment of Moss Adams LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2023 was approved based upon the following votes: Votes For Votes Against Abstentions Broker Non-Votes 14,574,768 11,880 9,917 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
REVIVA PHARMACEUTICALS HOLDINGS, INC. shareholders approved Election of each of Laxminarayan Bhat, Parag Saxena, Richard Margolin, Purav Patel and Les Funtleyder as directors at the 2023-11-13 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-11-13
Exact text from the filing
1. The election of each of Laxminarayan Bhat, Parag Saxena, Richard Margolin, Purav Patel and Les Funtleyder as directors to hold office for a term of one year, until their successor is duly elected and qualified or they are otherwise unable to complete their term. The votes were cast for this matter as follows: Votes Broker Non- Nominees Votes For Withheld Votes Laxminarayan Bhat 8,713,818 9,666 5,873,081 Parag Saxena 7,991,179 732,305 5,873,081 Richard Margolin 8,713,949 9,535 5,873,081 Purav Patel 8,713,807 9,677 5,873,081 Les Funtleyder 8,713,962 9,522 5,873,081
View on SEC.gov